Skip to Content

CIPLA 323 (Dimethyl Fumarate Delayed-Release 240 mg)

Pill with imprint CIPLA 323 is Green, Capsule-shape and has been identified as Dimethyl Fumarate Delayed-Release 240 mg. It is supplied by Cipla USA Inc..

Dimethyl fumarate is used in the treatment of multiple sclerosis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Dimethyl fumarate 240 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CIPLA 323

Dimethyl Fumarate Delayed-Release

Imprint
CIPLA 323
Strength
240 mg
Color
Green
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
Manufacturer
MSN Laboratories Private
National Drug Code (NDC)
69097-0323

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.